Compare, Analyse GSK Pharma with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs TEVA PHARMA (Israel) - Comparison Results

GSK PHARMA     Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 GSK PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    GSK PHARMA
Mar-19
TEVA PHARMA
Dec-13
GSK PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs3,5952,973-   
Low Rs1,2532,582-   
Sales per share (Unadj.) Rs184.71,706.1-  
Earnings per share (Unadj.) Rs26.3106.6-  
Cash flow per share (Unadj.) Rs29.2244.5-  
Dividends per share (Unadj.) Rs20.0093.30-  
Dividend yield (eoy) %0.83.4 24.6%  
Book value per share (Unadj.) Rs126.31,895.1-  
Shares outstanding (eoy) m169.40848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x13.11.6 806.3%   
Avg P/E ratio x92.226.1 353.8%  
P/CF ratio (eoy) x83.111.4 731.6%  
Price / Book Value ratio x19.21.5 1,309.3%  
Dividend payout %76.187.5 86.9%   
Avg Mkt Cap Rs m410,6262,355,388 17.4%   
No. of employees `0005.044.9 11.0%   
Total wages/salary Rs m5,3720-   
Avg. sales/employee Rs Th6,306.732,189.6 19.6%   
Avg. wages/employee Rs Th1,083.10-   
Avg. net profit/employee Rs Th898.02,010.9 44.7%   
INCOME DATA
Net Sales Rs m31,2811,446,763 2.2%  
Other income Rs m1,0230-   
Total revenues Rs m32,3041,446,763 2.2%   
Gross profit Rs m6,009396,197 1.5%  
Depreciation Rs m486116,943 0.4%   
Interest Rs m628,417 0.0%   
Profit before tax Rs m6,540250,837 2.6%   
Minority Interest Rs m01,140 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m287-164,661 -0.2%   
Tax Rs m2,373-3,062 -77.5%   
Profit after tax Rs m4,45490,378 4.9%  
Gross profit margin %19.227.4 70.1%  
Effective tax rate %36.3-1.2 -2,971.9%   
Net profit margin %14.26.2 227.9%  
BALANCE SHEET DATA
Current assets Rs m20,061977,138 2.1%   
Current liabilities Rs m14,543852,147 1.7%   
Net working cap to sales %17.68.6 204.2%  
Current ratio x1.41.1 120.3%  
Inventory Days Days5791 62.5%  
Debtors Days Days1496 14.7%  
Net fixed assets Rs m14,343472,545 3.0%   
Share capital Rs m1,6943,561 47.6%   
"Free" reserves Rs m19,7040-   
Net worth Rs m21,3981,607,079 1.3%   
Long term debt Rs m2739,762 0.0%   
Total assets Rs m39,1133,306,317 1.2%  
Interest coverage x1,091.09.8 11,102.0%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.80.4 182.8%   
Return on assets %11.43.6 317.4%  
Return on equity %20.85.6 370.1%  
Return on capital %31.94.9 647.5%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-6,5570-   
CASH FLOW
From Operations Rs m3,994230,539 1.7%  
From Investments Rs m-1,433-81,689 1.8%  
From Financial Activity Rs m-3,584-276,547 1.3%  
Net Cashflow Rs m-1,023-127,697 0.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 71.22 Rs / USD

Compare GSK PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare GSK PHARMA With: UNICHEM LAB  STRIDES PHARMA SCIENCE  LUPIN  STERLING BIOTECH  AJANTA PHARMA  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views On News

GSK PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 28.1% (Quarterly Result Update)

Jul 24, 2019 | Updated on Jul 24, 2019

For the quarter ended June 2019, GSK PHARMA has posted a net profit of Rs 1 bn (up 28.1% YoY). Sales on the other hand came in at Rs 8 bn (up 7.1% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of GSK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.

GSK PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 16.6% (Quarterly Result Update)

May 21, 2019 | Updated on May 21, 2019

For the quarter ended March 2019, GSK PHARMA has posted a net profit of Rs 1 bn (up 16.6% YoY). Sales on the other hand came in at Rs 8 bn (up 0.3% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

GSK PHARMA SHARE PRICE


Oct 18, 2019 (Close)

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK PHARMA - ALEMBIC LTD COMPARISON

COMPARE GSK PHARMA WITH

MARKET STATS